Commercial in Biological Technology

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to the...

PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations

SOUTH PLAINFIELD, N.J., June 1 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced that Clare Kennedy has been appointed as Vice President of Commercial Operations. In this role, she will report to Theresa Natalicchio, Senior Vice President, Commercial, and will be responsible for PTC's ...

Enerkem GreenField Alberta Biofuels Awarded Permit to Build World's First Commercial Municipal Waste-to-Biofuels Facility

Plant enables City of Edmonton to increase its waste diversion rate from 60 to 90% and to produce an alternative transportation fuel MONTREAL, May 20 /PRNewswire/ - Enerkem, a leading waste-to-biofuels technology company, today announced that Enerkem GreenField Alberta Biofuels (EGAB) has s...

BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III

ARLINGTON, Va., May 19 /PRNewswire/ -- BioInformatics, LLC ( http://www.gene2drug.com ) -- the leading market research and advisory firm serving the life science industry -- announces the publication of its latest report, "The Market for Antibodies: Keys to Success for Commercial Suppl...

Accuri Cytometers Adds Automation to Its Revolutionary C6 Flow Cytometer(R) System With Commercial Launch of CSampler(TM)

-Accuri CSampler Provides Simple, Reliable, Easy-to-Use and Affordable Automation for the C6 Flow Cytometer System- -Accuri Announces Opening of European Headquarters and Operations- -See CSampler at the Accuri Booth at Immunology 2009 and at the American Society of Microbiology 109th A...

SENOMYX ANNOUNCES NESTLE'S SELECTION OF A NEW FLAVOR INGREDIENT FOR EVALUATION OF COMMERCIAL POTENTIAL

SAN DIEGO, CA, May 5, 2009 /PRNewswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNMX ), a leading company focused on using proprietary technologies to discover and develop novel flavor ingredients for the food, beverage, and ingredient supply industries, announced today that Nestle SA has selected a...

Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species

RICHMOND, Calif., April 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today continued success of its zinc finger DNA-binding protein (ZFP) technology. New research published in the scientific journal Nature by licensing partner Dow AgroSciences and Sangamo de...

Medco Delivers First-Quarter 2009 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63; Reaffirms 2009 EPS Guidance; Announces Win of Coventry Commercial Business Starting January 1, 2010

First-Quarter 2009 Highlights: - GAAP diluted EPS increased 16.0 percent to $0.58 from $0.50 in first-quarter 2008 - Diluted EPS, excluding $0.05 in amortization of intangible assets from the 2003 spin-off, increased 14.5 percent to $0.63 from $0.55 in first-quarter 2008 - Total net...

ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells

ATHENS, Ga., March 27 /PRNewswire/ -- ArunA Biomedical, Inc., announced today that it will make its CELL-EZ(TM) brand hMC(TM) human mesenchymal progenitor cells commercially available to the research community in mid 2009. Derived from pluripotent human embryonic stem cells, ArunA's hMC lines wil...

PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies

INDIANAPOLIS, Feb. 24 /PRNewswire/ -- PDS Biotechnology today announced that the company has obtained an exclusive license from Merck Eprova AG to utilize Merck Eprova's proprietary chiral lipid DOTAP Chloride in Versamune(TM)-HPV and other products in development based on the Versamune(TM) te...

ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells

ATHENS, Ga., Jan. 30 /PRNewswire/ -- ArunA Biomedical, Inc., announced today that it will make its hN2(TM) cells commercially available to the research community in early 2009. The cells, derived from NIH registered human embryonic cell lines, are offered as a normal, consistent population of neu...

Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer

SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) announced today that Vincent P. Mihalik has been appointed Senior Vice President, Sales and Marketing and Chief Commercial Officer. Mr. Mihalik brings more than 30 years of experience across multiple co...

Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility

ROCKVILLE, Md., Jan. 26 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today that all equipment in its new Good Manufacturing Practice ("GMP") Pilot Plant to manufacture pandemic and seasonal influenza vaccine clinical supplies and commercial batches at a 1,000 liter scale...

Verenium Announces First Commercial Cellulosic Ethanol Project

- Large-scale cellulosic ethanol facility in Florida to serve as model for future plants - - "Farm to Fuel" grant provides State support to project - CAMBRIDGE, Mass., Jan. 15 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM ), a pioneer in the development of next-generatio...

Cell Therapeutics Targeting Potential Zevalin Label Expansion, Pixantrone and OPAXIO Drug Approvals to Grow Commercial Operations and Revenues in 2009

SEATTLE, Jan. 14 /PRNewswire-FirstCall/ -- In meetings held in association with the JP Morgan Healthcare Conference in San Francisco, Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) reviewed 2009 targeted milestones and 2008 accomplishments. CTI is seeking to obtain two new drug approvals...

Norton & Associates Inc. Adds $3bnUSD Commercial Real Estate Investment P & L Management Holding Group; US Property Portfolio Inc.

Robert H. Norton, MBA, PE, President of Norton & Associates with Divisions in NORTECH Realty, Investment, and Carbon Technology Management with the Carbon Credit Today. The group's announcement of a new holding corporation, US Property Portfolio, private equity land investments and the acqu...

Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-Based Diagnostic Test: miRview(TM) meso

REHOVOT, Israel, JERSEY CITY, New Jersey and PHILADELPHIA, Pennsylvania, December 29 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), the leading developer of microRNA-based molecular diagnostics, announced today the introduction of its third diagnostic test, miRview(TM) meso. T...

NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance

SOPHIA ANTIPOLIS, France, December 2 /PRNewswire-FirstCall/ -- NicOx S.A. (NYSE Euronext Paris: COX) today announced it has signed an agreement with DSM for the commercial manufacture and supply of naproxcinod drug substance (or API, active pharmaceutical ingredient). Naproxcinod is NicOx' lea...

DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter

PARSIPPANY, N.J. and LEIDEN, Netherlands, Nov. 25 /PRNewswire/ -- DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. (Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX), today announced that Hungary-based Gedeon Richter Plc. signed a commercial...

Poniard Pharmaceuticals Announces Commercial Supply Agreement for Picoplatin

SOUTH SAN FRANCISCO, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on oncology, today announced an agreement with Baxter Oncology GmbH for the commercial manufacture and supply of injectable picoplatin drug product. P...

MiddleBrook Pharmaceuticals Hires Key Commercial Team Members

Company prepares to launch Moxatag(TM), the first and only FDA-approved once-daily amoxicillin, in the first quarter of 2009 GERMANTOWN, Md., Nov. 19 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK ), today announced it has hired the following key commercial te...

Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine

ExCeltrix Preliminary Oncology Data Presented for the First Time San Diego, CA (PRWEB) November 17, 2008 -- Dr. Gail Naughton, CEO of Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today addressed atten...

Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale

CALGARY, Oct. 8 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that it has successfully completed initial scale up of its manufacturing process for REOLYSIN(R) to commercial scale. The scale up of primary production and downstream proce...

NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules

SOPHIA ANTIPOLIS, France, September 23 /PRNewswire-FirstCall/ -- NicOx S.A. (Euronext Paris: COX) today announced it has signed an exclusive agreement with Capsugel, the leading producer of two-piece capsules, for the commercial manufacturing and global supply of naproxcinod capsules. Naproxci...

CMS, Inc., an Elekta Company, Announces Commercial Availability of Focal4D(TM)

ST LOUIS, Sept. 15 /PRNewswire/ -- CMS, Inc., an Elekta Company and worldwide leader in radiation treatment planning and workflow management solutions, today announced the commercial launch of its new 4D treatment planning solution, Focal4D(TM). Focal4D, part of the Focal product line that a...

Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership

Appoints Stephen Ross Senior Vice President of Commercial Operations and James Briggs Senior Vice President of Human Resources CLINTON, N.J., Aug. 25 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biotherapeutics company, announced today the addition of two key execu...

VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent

- First Product Developed from the VisEn-Merck & Co., Inc. Biomarker Imaging Program - - Expands VisEn's Leading Fluorescence Molecular Imaging Agent Portfolio and Broadens Applications in Key Areas of Disease Research and Drug Development - BEDFORD, Mass., Aug. 19 /PRNewswire/ -- VisEn Me...

XTELL Launches its Commercial Biorepository Services for Research and Pharmaceutical Companies

XTELL has launched a commercial biorepository service, bioVAULT, which stores, manages and processes large numbers of biological specimens. BioVAULT is targeting scientific and pharmaceutical companies investigating new drug and diagnostic development. Athens, OH (PRWEB...

Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning

EAST NORRITON, Pa., July 23 /PRNewswire/ -- Tengion Inc., a clinical stage biotechnology company focused on the development of neo-organs and neo-tissues, today announced that it has appointed Mark Stejbach as Vice President, Marketing and Commercial Planning. Mr. Stejbach brings more than twe...

AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy

AMSTERDAM, The Netherlands, July 15 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced the start of a collaboration with St. Jude Children's Research Hospital in Memphis, Tennessee, USA, on the development of...

Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification

SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM ) and its operating unit InnerCool Therapies, Inc., announced today that InnerCool's RapidBlue(TM) endovascular temperature modulation system conforms to the European Union CE Mark requirements for use in inducing, m...

Pacific Biosciences Raises $100 Million to Fund Commercial Product Development

MENLO PARK, Calif., July 14 /PRNewswire/ -- Pacific Biosciences announced today that it has secured $100 million in a Series E private equity financing round. The proceeds will be used to fund the commercial development of the company's innovative single-molecule, real-time (SMRT(TM)) DNA sequ...

Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems

FREMONT, Calif., July 1 /PRNewswire/ -- Microfluidic Systems Inc. (MFSI) announced today that it has been awarded the Phase 3X agreement for the production of Microfluidic - Bioagent Autonomous Networked Detector (M-BAND). This award is the fourth in a series of funded phases by the DHS Scienc...

Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer

Summary: Exiqon Today Announced the Appointment of Cynthia K. French, Ph.D. as Chief Scientific Officer and Erik Holmlin, Ph.D. as Chief Commercial Officer VEDBAEK, Denmark, June 30 /PRNewswire-FirstCall/ -- Cynthia K. French joins Exiqon from Affymetrix where sh...

Portola Pharmaceuticals Names William Lis Vice President of Business Development and Commercial Operations

SOUTH SAN FRANCISCO, Calif., June 24 /PRNewswire/ -- Portola Pharmaceuticals, a clinical-stage biopharmaceutical developing best-in-class therapeutics for acute and chronic cardiovascular and inflammatory diseases, today announced that Bill Lis has joined the company as Vice President of Busin...

Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants

Dow AgroSciences Will Sublicense Sangamo's Technology in Plant Agriculture Under the Trademark EXZACT(TM) Precision Traits SAN DIEGO, June 18 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW ), announced today at the 20...

Campbell Alliance Trade and Distribution Practice to Speak at CBI's Commercial Contracts and Chargeback Management Conference

RALEIGH, N.C., June 10 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that executives from the firm's Trade and Distribution Practice will present at the Center for Business Intelligence (CBI) 4...

Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales

MONTVALE, N.J., May 12 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI ) is increasing the Company's commercial focus with the appointment of David C. Tantillo as Senior Director, Marketing and Sales, a newly created position. Beginning today, Mr. Tantillo will be responsible...

Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay

SensiTrop II accurately classifies Dual/Mixed tropic HIV patients with samples provided by Pfizer. MALIBU, Calif., May 7 /PRNewswire/ -- Pathway Diagnostics announces nationwide availability of its patented second generation molecular SensiTrop(TM) II assay, combining the...

Kendle Appoints Patricia Williams Vice President, Commercial Operations

Industry Veteran to Lead Global Contract Execution and Negotiation Efforts CINCINNATI, May 6 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL ), a leading, global full-service clinical research organization (CRO), today announced the appointment of Patricia Williams to the position of Vice Presi...